JAK2 (phospho Tyr1007/1008) antibody
GTX132784
Overview
- SupplierGeneTex
- Product NameJAK2 (phospho Tyr1007/1008) antibody
- Delivery Days Customer9
- Application Supplier NoteWB: 1:500-1:3000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsWestern Blot
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration0.25 mg/ml
- ConjugateUnconjugated
- Gene ID3717
- Target nameJAK2
- Target descriptionJanus kinase 2
- Target synonymsJAK-2; Janus kinase 2 (a protein tyrosine kinase); JTK10; tyrosine-protein kinase JAK2
- HostRabbit
- IsotypeIgG
- Protein IDO60674
- Protein NameTyrosine-protein kinase JAK2
- Scientific DescriptionThis gene product is a protein tyrosine kinase involved in a specific subset of cytokine receptor signaling pathways. It has been found to be constituitively associated with the prolactin receptor and is required for responses to gamma interferon. Mice that do not express an active protein for this gene exhibit embryonic lethality associated with the absence of definitive erythropoiesis. [provided by RefSeq]
- ReactivityHuman, Mouse
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203
References
- Cisplatin or Doxorubicin Reduces Cell Viability via the PTPIVA3-JAK2-STAT3 Cascade in Hepatocellular Carcinoma.Read more
- Water extract of medicinal ink (WEMI) attenuates lipopolysaccharide-induced NO production of Raw264.7 cells via downregulating JAK2/STAT3-mediated iNOS expression. Lin ZH et al., 2022 Jan 10, J EthnopharmacolRead more
- Inhibition of ATM reverses EMT and decreases metastatic potential of cisplatin-resistant lung cancer cells through JAK/STAT3/PD-L1 pathway. Shen M et al., 2019 Apr 8, J Exp Clin Cancer ResRead more